Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Sangamo Biosciences (SGMO)
NASDAQ:SGMO
Sangamo Biosciences (SGMO) Stock Price & Analysis
1,425 Followers
SGMO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.58 - $6.42
Previous Close$1.74
Volume2.77M
Average Volume (3M)1.66M
Market Cap
$293.16M
Enterprise Value$58.64M
Total Cash (Recent Filing)$277.63M
Total Debt (Recent Filing)$43.11M
Price to Earnings (P/E)-1.4
Beta1.25
Next Earnings
May 10, 2023EPS Estimate
-$0.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.24
Shares Outstanding192,903,474
10 Day Avg. Volume2,245,680
30 Day Avg. Volume1,662,846
Standard Deviation0.18
R-Squared0.13
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.55
Price to Sales (P/S)2.88
Price to Cash Flow (P/CF)11.50
P/FCF Ratio-1.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.53
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.32
Forecast
1Y Price Target
$10.89Price Target Upside540.59% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Sangamo Biosciences News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SGMO FAQ
What was Sangamo Biosciences’s price range in the past 12 months?
Sangamo Biosciences lowest stock price was $1.58 and its highest was $6.42 in the past 12 months.
What is Sangamo Biosciences’s market cap?
Currently, no data Available
When is Sangamo Biosciences’s upcoming earnings report date?
Sangamo Biosciences’s upcoming earnings report date is May 10, 2023 which is in 42 days.
How were Sangamo Biosciences’s earnings last quarter?
Sangamo Biosciences released its earnings results on Feb 22, 2023. The company reported -$0.32 earnings per share for the quarter, beating the consensus estimate of -$0.36 by $0.04.
Is Sangamo Biosciences overvalued?
According to Wall Street analysts Sangamo Biosciences’s price is currently Undervalued.
Does Sangamo Biosciences pay dividends?
Sangamo Biosciences does not currently pay dividends.
What is Sangamo Biosciences’s EPS estimate?
Sangamo Biosciences’s EPS estimate is -$0.33.
How many shares outstanding does Sangamo Biosciences have?
Sangamo Biosciences has 168,483,320 shares outstanding.
What happened to Sangamo Biosciences’s price movement after its last earnings report?
Sangamo Biosciences reported an EPS of -$0.32 in its last earnings report, beating expectations of -$0.36. Following the earnings report the stock price went up 0.344%.
Which hedge fund is a major shareholder of Sangamo Biosciences?
Among the largest hedge funds holding Sangamo Biosciences’s share is Caxton Associates LP. It holds Sangamo Biosciences’s shares valued at 518K.
---
Sangamo Biosciences Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.89 (540.59% Upside)
$10.89 (540.59% Upside)
Blogger Sentiment
Bullish
SGMO Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 165.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.1%
Last 30 Days ▲ 12.6%
Last 30 Days ▲ 12.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-69.73%
12-Months-Change
Fundamentals
Return on Equity
-57.37%
Trailing 12-Months
Asset Growth
-22.08%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Sangamo Biosciences
Sangamo Therapeutics, Inc. engages in researching and developing transcription factors in the regulation of genes. It focuses on the research, development and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation technology platform is enabled by the engineering of a class of transcription factors known as zinc finger DNA-binding proteins. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.
---
Top 5 ETFs holding SGMO
BMO MSCI Innovation Index ETF
$2.89K
Up to five ETFs with an Outperform Smart Score that hold SGMO. The ETFs are listed according to market value of SGMO within the ETF
---
HilleVax, Inc
―
Vanda
―
Sorrento Therapeutics
―
Emergent Biosolutions
―
Intercept Pharma
―
---